Clinical Trial Update: Treatment Substitution With PRO 140 Monotherapy in Adult Subjects With HIV-1 Infection [Phase 2]

View source ↗

Summary

Phase 2 trial update on treatment substitution with PRO 140 monotherapy in adults with HIV-1 infection; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Disease
• Human Immunodeficiency Virus Infection

Drugs mentioned

• PRO 140 (leronlimab)

Snippet

Sponsor: CytoDyn, Inc. | Conditions: HIV, Human Immunodeficiency Virus | Phase 2 | Status: COMPLETED | Results posted: 2023-04-14